RESUMEN
We report a case of drug-induced lupus erythematosus (DILE) secondary to trimethoprim/sulfamethoxazole (TMP/SMX) in a patient with underlying inflammatory bowel disease (IBD). The initial presentation was with febrile pleural and pericardial effusions followed by cardiac tamponade. The patient was treated with a short course of corticosteroids with complete resolution of symptoms. To our knowledge this is the first reported case of TMP/SMX-induced DILE presenting with life-threatening serositis. When confronted with sterile exudative effusions, clinicians should strongly consider non-infectious etiologies.
Asunto(s)
Corticoesteroides/uso terapéutico , Taponamiento Cardíaco/diagnóstico por imagen , Lupus Eritematoso Sistémico/complicaciones , Derrame Pleural/diagnóstico por imagen , Serositis/tratamiento farmacológico , Combinación Trimetoprim y Sulfametoxazol/efectos adversos , Taponamiento Cardíaco/etiología , Femenino , Humanos , Enfermedades Inflamatorias del Intestino/tratamiento farmacológico , Lupus Eritematoso Sistémico/inducido químicamente , Persona de Mediana Edad , Derrame Pleural/etiología , Serositis/etiología , Tomografía Computarizada por Rayos X , Combinación Trimetoprim y Sulfametoxazol/uso terapéuticoRESUMEN
Psittacosis is a zoonotic infectious disease caused by the transmission of Chlamydia psittaci; it often presents as a pulmonary infection but rarely as disseminated disease. Because diagnoses of psittacosis are often underreported due to infrequent pathogen-specific testing, clinical metagenomic next-generation sequencing may be helpful to diagnose such an uncommon syndrome.